Soleno TherapeuticsSLNO
那斯達克 · USD
86.04
-0.43
(-0.50%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Soleno TherapeuticsSLNO
86.04
-0.43
(-0.50%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 45,743 | 59,116 | 80,212 | 24,868 | - | 13,910 | 10,382 | 8,623 | 8,469 | 5,610 |
研發費用 | 13,517 | 21,486 | 30,138 | 12,342 | 14,602 | 8,689 | 6,043 | 5,141 | 5,316 | 3,810 |
推銷及管理費用 | 32,226 | 37,630 | 50,074 | 12,526 | 8,873 | 5,221 | 4,339 | 3,482 | 3,153 | 1,800 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -45,743 | -59,116 | -80,212 | -24,868 | -23,475 | -13,910 | -10,382 | -8,623 | -8,469 | -5,610 |
其他收入及費用 | 3,331 | 3,365 | 3,596 | 3,014 | 2,077 | 2,614 | -479 | 148 | 113 | 124 |
利息費用 | 1,361 | 231 | - | - | - | - | - | - | - | - |
稅前純益 | -43,773 | -55,982 | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 | -8,475 | -8,356 | -5,486 |
所得稅 | - | - | - | - | - | - | - | - | - | - |
稅後純益 | -43,773 | -55,982 | -76,616 | -21,854 | -21,398 | -11,296 | -10,861 | -8,475 | -8,356 | -5,486 |
基本每股稅後盈餘(元) | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | - | -0.95 | -0.81 | -0.88 | -0.58 |
稀釋每股稅後盈餘(元) | -0.95 | -1.30 | -1.92 | -0.57 | -0.59 | 0.29 | -0.96 | -0.81 | -0.88 | -0.56 |
基本平均股數(千股) | 46178.00 | 43924.00 | 41879.00 | 38631.00 | 36208.00 | - | 11436.00 | 10423.00 | 9447.00 | 9440.00 |
稀釋平均股數(千股) | 46178.00 | 43924.00 | 41879.00 | 38631.00 | 36208.00 | - | 11436.00 | 10423.00 | 9447.00 | 9440.00 |
還原基本每股稅後盈餘(元) | -0.95 | -1.27 | -1.83 | -0.57 | -0.59 | - | -0.95 | -0.81 | -0.88 | -0.58 |
還原稀釋每股稅後盈餘(元) | -0.95 | -1.30 | -1.92 | -0.57 | -0.59 | 0.29 | -0.96 | -0.81 | -0.88 | -0.56 |
還原基本平均股數(千股) | 46,178 | 43,924 | 41,879 | 38,631 | 36,208 | - | 11,436 | 10,423 | 9,447 | 9,440 |
還原稀釋平均股數(千股) | 46,178 | 43,924 | 41,879 | 38,631 | 36,208 | - | 11,436 | 10,423 | 9,447 | 9,440 |
EBITDA(千元) | -42,880 | -56,648 | -78,025 | -22,473 | -21,381 | -10,807 | -10,371 | -7,986 | -7,866 | -4,998 |